Fundación Andaluza de Reumatología
1 clinical trials · Sponsor
◉ Watch Fundación Andaluza de Reumatología
| Record | Firm | Date |
|---|---|---|
| Study to Assess the Management of Synthetic Disease-modifying Antirheumatic Drug (DMARD) at the Onset of Adverse Events, Intolerance or Lack of Efficacy in Rheumatoid Arthritis (RA) (NCT02094326) | Fundación Andaluza de Reumatología | 2014-03-01 |
Track Fundación Andaluza de Reumatología automatically
Every clearance here is in the API, with alerts when new ones post.